{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:39:54Z","timestamp":1790959194094,"version":"4.1.0"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.cellsig.2023.110847","type":"journal-article","created":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T20:43:29Z","timestamp":1691441009000},"page":"110847","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Cancer Cachexia and breast cancer stem cell signalling \u2013 A crosstalk of signalling molecules"],"prefix":"10.1016","volume":"110","author":[{"given":"Priyanka","family":"Shivnani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saroj","family":"Shekhawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akhilesh","family":"Prajapati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.cellsig.2023.110847_bb0005","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1158\/1078-0432.CCR-06-2307","article-title":"Cancer cachexia signaling pathways continue to emerge yet much still points to the proteasome","volume":"13","author":"Acharyya","year":"2007","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.cellsig.2023.110847_bb0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4251\/wjgo.v7.i4.17","article-title":"Cancer cachexia, mechanism and treatment","volume":"7","author":"Aoyagi","year":"2015","journal-title":"World J. Gastrointest. Oncol."},{"issue":"1","key":"10.1016\/j.cellsig.2023.110847_bb0015","doi-asserted-by":"crossref","first-page":"7960","DOI":"10.4081\/ejtm.2019.7960","article-title":"Therapeutic strategies against cancer cachexia","volume":"29","author":"Argil\u00e9s","year":"2019","journal-title":"Europ. J. Transl. Myol."},{"issue":"4","key":"10.1016\/j.cellsig.2023.110847_bb0020","first-page":"408","article-title":"Oxidative stress as a therapeutic target during muscle wasting: considering the complex interactions","volume":"11","author":"Arthur","year":"2008","journal-title":"Curr. Opin. Clin. Nutrit. Metab. Care"},{"issue":"3","key":"10.1016\/j.cellsig.2023.110847_bb0025","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3390\/cancers11030285","article-title":"Moderate exercise improves experimental Cancer Cachexia by modulating the redox homeostasis","volume":"11","author":"Ballar\u00f2","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.cellsig.2023.110847_bb0030","first-page":"658","article-title":"Reactive oxygen species: oxidative damage and pathogenesis","author":"Bandyopadhyay","year":"1999","journal-title":"Curr. Sci."},{"issue":"28","key":"10.1016\/j.cellsig.2023.110847_bb0035","doi-asserted-by":"crossref","first-page":"43442","DOI":"10.18632\/oncotarget.9779","article-title":"Chemotherapy-related cachexia is associated with mitochondrial depletion and the activation of ERK1\/2 and p38 MAPKs","volume":"7","author":"Barreto","year":"2016","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.cellsig.2023.110847_bb0040","doi-asserted-by":"crossref","first-page":"E410","DOI":"10.1152\/ajpendo.00039.2012","article-title":"JAK\/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia","volume":"303","author":"Bonetto","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.cellsig.2023.110847_bb0045","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.cell.2004.09.027","article-title":"IKKbeta\/NF-kappaB activation causes severe muscle wasting in mice","volume":"119","author":"Cai","year":"2004","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.cellsig.2023.110847_bb0050","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nrc3483","article-title":"Cancer metabolism: fatty acid oxidation in the limelight","volume":"13","author":"Carracedo","year":"2013","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2023.110847_bb0055","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1038\/s41467-018-05220-6","article-title":"Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer","volume":"9","author":"Cazet","year":"2018","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.cellsig.2023.110847_bb0060","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1002\/jcp.24611","article-title":"Pharmacological strategies in lung cancer-induced cachexia: effects on muscle proteolysis, autophagy, structure, and weakness","volume":"229","author":"Chacon-Cabrera","year":"2014","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.cellsig.2023.110847_bb0065","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40169-018-0205-6","article-title":"Cytokines, breast cancer stem cells (BCSCs) and chemoresistance","volume":"7","author":"Chen","year":"2018","journal-title":"Clin. Transl. Med."},{"issue":"7","key":"10.1016\/j.cellsig.2023.110847_bb0070","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.cell.2014.11.020","article-title":"Acetate dependence of tumors","volume":"159","author":"Comerford","year":"2014","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.cellsig.2023.110847_bb0080","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.3390\/ijms19082225","article-title":"mTOR and tumor Cachexia","volume":"19","author":"Duval","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.cellsig.2023.110847_bb0085","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet. Oncol."},{"issue":"2","key":"10.1016\/j.cellsig.2023.110847_bb0090","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.gendis.2018.05.001","article-title":"Breast cancer development and progression: risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis","volume":"5","author":"Feng","year":"2018","journal-title":"Genes Diseas."},{"issue":"6","key":"10.1016\/j.cellsig.2023.110847_bb0095","first-page":"1809","article-title":"A predictive model of inflammatory markers and patient-reported symptoms for cachexia in newly diagnosed pancreatic cancer patients","volume":"25","author":"Fogelman","year":"2017","journal-title":"Support. Care Cancer"},{"issue":"6","key":"10.1016\/j.cellsig.2023.110847_bb0100","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/nm.4093","article-title":"Excessive fatty acid oxidation induces muscle atrophy in cancer cachexia","volume":"22","author":"Fukawa","year":"2016","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.cellsig.2023.110847_bb0105","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/jcsm.12854","article-title":"Activation of Akt-mTORC1 signalling reverts cancer-dependent muscle wasting","volume":"13","author":"Geremia","year":"2022","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"7412","key":"10.1016\/j.cellsig.2023.110847_bb0110","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/nature11480","article-title":"Cancer: resolving the stem-cell debate","volume":"488","author":"Gilbertson","year":"2012","journal-title":"Nature"},{"issue":"25","key":"10.1016\/j.cellsig.2023.110847_bb0120","doi-asserted-by":"crossref","first-page":"14440","DOI":"10.1073\/pnas.251541198","article-title":"Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy","volume":"98","author":"Gomes","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.cellsig.2023.110847_bb0125","doi-asserted-by":"crossref","first-page":"R68","DOI":"10.1152\/ajpregu.00028.2019","article-title":"Tissue-specific dysregulation of mitochondrial respiratory capacity and coupling control in colon-26 tumor-induced cachexia","volume":"317","author":"Halle","year":"2019","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"1","key":"10.1016\/j.cellsig.2023.110847_bb0130","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12964-018-0309-z","article-title":"Adipocyte-derived IL-6 and leptin promote breast cancer metastasis via upregulation of Lysyl Hydroxylase-2 expression","volume":"16","author":"He","year":"2018","journal-title":"Cell Commun. Signal."},{"issue":"Pt 1","key":"10.1016\/j.cellsig.2023.110847_bb0135","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1113\/jphysiol.1997.sp021855","article-title":"Xanthine oxidase in human skeletal muscle following eccentric exercise: a role in inflammation","volume":"498","author":"Hellsten","year":"1997","journal-title":"J. Physiol."},{"issue":"12","key":"10.1016\/j.cellsig.2023.110847_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085737","article-title":"Syndecan-1 (CD138) modulates triple-negative breast cancer stem cell properties via regulation of LRP-6 and IL-6-mediated STAT3 signaling","volume":"8","author":"Ibrahim","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.cellsig.2023.110847_bb0150","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/nrc1804","article-title":"Mapping normal and cancer cell signalling networks: towards single-cell proteomics","volume":"6","author":"Irish","year":"2006","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.cellsig.2023.110847_bb0155","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.cell.2015.08.031","article-title":"Targeting of Fn14 prevents cancer-induced Cachexia and prolongs survival","volume":"162","author":"Johnston","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.cellsig.2023.110847_bb0160","first-page":"43","article-title":"Current therapeutic targets in cancer Cachexia: a pathophysiologic approach","volume":"2023","author":"Kadakia","year":"2023","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"issue":"2","key":"10.1016\/j.cellsig.2023.110847_bb0165","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.canlet.2004.12.005","article-title":"Glutathione peroxidase, glutathione-S-transferase, catalase, xanthine oxidase, cu-Zn superoxide dismutase activities, total glutathione, nitric oxide, and malondialdehyde levels in erythrocytes of patients with small cell and non-small cell lung cancer","volume":"227","author":"Kaynar","year":"2005","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.cellsig.2023.110847_bb0170","doi-asserted-by":"crossref","first-page":"9511","DOI":"10.1038\/s41598-018-27864-6","article-title":"GRAMD1B regulates cell migration in breast cancer cells through JAK\/STAT and Akt signaling","volume":"8","author":"Khanna","year":"2018","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.cellsig.2023.110847_bb0175","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1172\/JCI57099","article-title":"Breast cancer stem cells, cytokine networks, and the tumor microenvironment","volume":"121","author":"Korkaya","year":"2011","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.cellsig.2023.110847_bb0180","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1158\/0008-5472.CAN-15-1439","article-title":"STK11\/LKB1 deficiency promotes neutrophil recruitment and Proinflammatory cytokine production to suppress T-cell activity in the lung tumor microenvironment","volume":"76","author":"Koyama","year":"2016","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.cellsig.2023.110847_bb0185","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1152\/japplphysiol.00085.2007","article-title":"Exercise, MAPK, and NF-kappaB signaling in skeletal muscle","volume":"103","author":"Kramer","year":"2007","journal-title":"J. Appl. Physiol. (Bethesda, Md. 1985)"},{"issue":"1","key":"10.1016\/j.cellsig.2023.110847_bb0190","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1158\/0008-5472.CAN-11-2178","article-title":"A dynamic inflammatory cytokine network in the human ovarian cancer microenvironment","volume":"72","author":"Kulbe","year":"2012","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.cellsig.2023.110847_bb0200","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1096\/fj.04-2364com","article-title":"TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1\/MAFbx in skeletal muscle","volume":"19","author":"Li","year":"2005","journal-title":"FASEB J."},{"issue":"5","key":"10.1016\/j.cellsig.2023.110847_bb0205","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/jcsm.12441","article-title":"Tumour-derived transforming growth factor-\u03b2 signalling contributes to fibrosis in patients with cancer cachexia","volume":"10","author":"Lima","year":"2019","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"5","key":"10.1016\/j.cellsig.2023.110847_bb0210","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/jcsm.12441","article-title":"Tumour-derived transforming growth factor-\u03b2 signalling contributes to fibrosis in patients with cancer cachexia","volume":"10","author":"Lima","year":"2019","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"5","key":"10.1016\/j.cellsig.2023.110847_bb0215","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1210\/jc.2014-4318","article-title":"Role of Activin a and myostatin in human cancer cachexia","volume":"100","author":"Loumaye","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.cellsig.2023.110847_bb0220","doi-asserted-by":"crossref","first-page":"622","DOI":"10.15252\/emmm.201607052","article-title":"STAT3 promotes IFN\u03b3\/TNF\u03b1-induced muscle wasting in an NF-\u03baB-dependent and IL-6-independent manner","volume":"9","author":"Ma","year":"2017","journal-title":"EMBO Mol. Med."},{"issue":"10","key":"10.1016\/j.cellsig.2023.110847_bb0230","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1007\/s00109-003-0476-1","article-title":"Antioxidant agents are effective in inducing lymphocyte progression through cell cycle in advanced cancer patients: assessment of the most important laboratory indexes of cachexia and oxidative stress","volume":"81","author":"Mantovani","year":"2003","journal-title":"J. Mol. Med. (Berlin, Germany)"},{"issue":"7","key":"10.1016\/j.cellsig.2023.110847_bb0235","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1172\/JCI44745","article-title":"The JAK2\/STAT3 signaling pathway is required for growth of CD44+CD24\u2212 stem cell-like breast cancer cells in human tumors","volume":"121","author":"Marotta","year":"2011","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.cellsig.2023.110847_bb0240","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.cell.2004.12.007","article-title":"Molecular mechanisms of muscle atrophy","volume":"119","author":"McKinnell","year":"2004","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.cellsig.2023.110847_bb0245","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/sj.mn.7800136","article-title":"The physiology of endothelial xanthine oxidase: from urate catabolism to reperfusion injury to inflammatory signal transduction","volume":"9","author":"Meneshian","year":"2002","journal-title":"Microcirc. (New York, N.Y.: 1994)"},{"issue":"5","key":"10.1016\/j.cellsig.2023.110847_bb0250","first-page":"1239","article-title":"The AP-1\/NF-kappaB double inhibitor SP100030 can revert muscle wasting during experimental cancer cachexia","volume":"30","author":"Moore-Carrasco","year":"2007","journal-title":"Int. J. Oncol."},{"issue":"11","key":"10.1016\/j.cellsig.2023.110847_bb0255","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1172\/JCI63930","article-title":"Adipocyte-derived endotrophin promotes malignant tumor progression","volume":"122","author":"Park","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.cellsig.2023.110847_bb0260","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cell.2009.12.007","article-title":"Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content","volume":"140","author":"Pece","year":"2010","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.cellsig.2023.110847_bb0265","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1038\/s41598-017-02088-2","article-title":"Cancer cachexia associates with a systemic autophagy-inducing activity mimicked by cancer cell-derived IL-6 trans-signaling","volume":"7","author":"Pettersen","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.cellsig.2023.110847_bb0270","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/jcsm.12489","article-title":"Autocrine activin a signalling in ovarian cancer cells regulates secretion of interleukin 6, autophagy, and cachexia","volume":"11","author":"Pettersen","year":"2020","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"9","key":"10.1016\/j.cellsig.2023.110847_bb0275","doi-asserted-by":"crossref","first-page":"5384","DOI":"10.1073\/pnas.0931260100","article-title":"Cancer cachexia: its correlations and causes","volume":"100","author":"Rubin","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.cellsig.2023.110847_bb0280","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.freeradbiomed.2011.04.002","article-title":"Inhibition of xanthine oxidase reduces oxidative stress and improves skeletal muscle function in response to electrically stimulated isometric contractions in aged mice","volume":"51","author":"Ryan","year":"2011","journal-title":"Free Radic. Biol. Med."},{"issue":"7","key":"10.1016\/j.cellsig.2023.110847_bb0285","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1158\/0008-5472.CAN-15-1360","article-title":"Aspirin suppresses the acquisition of chemoresistance in breast cancer by disrupting an NF\u03baB-IL6 signaling Axis responsible for the generation of cancer stem cells","volume":"76","author":"Saha","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2023.110847_bb0290","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.biochi.2018.04.009","article-title":"Effects of the beta2 agonist formoterol on atrophy signaling, autophagy, and muscle phenotype in respiratory and limb muscles of rats with cancer-induced cachexia","volume":"149","author":"Salazar-Degracia","year":"2018","journal-title":"Biochimie"},{"issue":"12","key":"10.1016\/j.cellsig.2023.110847_bb0295","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1172\/JCI32533","article-title":"IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland","volume":"117","author":"Sansone","year":"2007","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.cellsig.2023.110847_bb0300","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.stemcr.2020.06.020","article-title":"Increased expression of Interleukin-1 receptor characterizes anti-estrogen-resistant ALDH+ breast cancer stem cells","volume":"15","author":"Sarmiento-Castro","year":"2020","journal-title":"Stem Cell Rep."},{"issue":"3","key":"10.1016\/j.cellsig.2023.110847_bb0310","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.ccell.2020.06.007","article-title":"IL6\/STAT3 signaling hijacks estrogen receptor \u03b1 enhancers to drive breast cancer metastasis","volume":"38","author":"Siersb\u00e6k","year":"2020","journal-title":"Cancer Cell"},{"issue":"17","key":"10.1016\/j.cellsig.2023.110847_bb0315","doi-asserted-by":"crossref","first-page":"11177","DOI":"10.1074\/jbc.M115.641514","article-title":"Inhibition of Stat3 activation suppresses caspase-3 and the ubiquitin-proteasome system, leading to preservation of muscle mass in cancer cachexia","volume":"290","author":"Silva","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.cellsig.2023.110847_bb0320","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s13287-021-02321-w","article-title":"Signaling pathways governing breast cancer stem cells behavior","volume":"12","author":"Song","year":"2021","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.cellsig.2023.110847_bb0325","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2147\/CMAR.S225376","article-title":"EGFR promotes the development of triple negative breast cancer through JAK\/STAT3 signaling","volume":"12","author":"Song","year":"2020","journal-title":"Cancer Manag. Res."},{"issue":"5","key":"10.1016\/j.cellsig.2023.110847_bb0330","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1172\/JCI115767","article-title":"Evidence for the involvement of interleukin 6 in experimental cancer cachexia","volume":"89","author":"Strassmann","year":"1992","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.cellsig.2023.110847_bb0335","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13048-019-0586-1","article-title":"Withaferin a ameliorates ovarian cancer-induced cachexia and proinflammatory signaling","volume":"12","author":"Straughn","year":"2019","journal-title":"J. Ovar. Res."},{"issue":"3","key":"10.1016\/j.cellsig.2023.110847_bb0340","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s13539-011-0037-3","article-title":"Decreased NADPH oxidase expression and antioxidant activity in cachectic skeletal muscle","volume":"2","author":"Sullivan-Gunn","year":"2011","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"10.1016\/j.cellsig.2023.110847_bb0365","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.cyto.2018.03.020","article-title":"Cytokine-mediated therapeutic resistance in breast cancer","volume":"108","author":"Tan","year":"2018","journal-title":"Cytokine"},{"issue":"6","key":"10.1016\/j.cellsig.2023.110847_bb0370","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00003465-200411000-00001","article-title":"The biochemical basis of metabolism in cancer cachexia","volume":"23","author":"Tijerina","year":"2004","journal-title":"Dimens. Critic. Care Nurs."},{"issue":"10","key":"10.1016\/j.cellsig.2023.110847_bb0375","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/nri1937","article-title":"Adipocytokines: mediators linking adipose tissue, inflammation and immunity","volume":"6","author":"Tilg","year":"2006","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.cellsig.2023.110847_bb0385","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.cell.2010.08.004","article-title":"Reversing cachexia","volume":"142","author":"Tisdale","year":"2010","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.cellsig.2023.110847_bb0390","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1002\/ijc.29930","article-title":"Complete reversal of muscle wasting in experimental cancer cachexia: additive effects of activin type II receptor inhibition and \u03b2-2 agonist","volume":"138","author":"Toledo","year":"2016","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2023.110847_bb0400","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.biocel.2006.07.001","article-title":"Free radicals and antioxidants in normal physiological functions and human disease","volume":"39","author":"Valko","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"2","key":"10.1016\/j.cellsig.2023.110847_bb0405","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s13539-012-0087-1","article-title":"Cancer cachexia: impact, mechanisms and emerging treatments","volume":"4","author":"Vaughan","year":"2013","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"3","key":"10.1016\/j.cellsig.2023.110847_bb0410","article-title":"Proteasome expression and activity in cancer and cancer stem cells","volume":"39","author":"Voutsadakis","year":"2017","journal-title":"Tumour Biol. J. Int. Soc. Oncodevelopm. Biol. Med."},{"issue":"3","key":"10.1016\/j.cellsig.2023.110847_bb0415","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.bbrc.2018.07.088","article-title":"Interleukin-22 promotes triple negative breast cancer cells migration and paclitaxel resistance through JAK-STAT3\/MAPKs\/AKT signaling pathways","volume":"503","author":"Wang","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.cellsig.2023.110847_bb0420","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cmet.2017.11.001","article-title":"JAK\/STAT3-regulated fatty acid \u03b2-oxidation is critical for breast cancer stem cell self-renewal and Chemoresistance","volume":"27","author":"Wang","year":"2018","journal-title":"Cell Metab."},{"issue":"5","key":"10.1016\/j.cellsig.2023.110847_bb0430","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S1357-2725(02)00341-2","article-title":"Sepsis upregulates the gene expression of multiple ubiquitin ligases in skeletal muscle","volume":"35","author":"Wray","year":"2003","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"5","key":"10.1016\/j.cellsig.2023.110847_bb0435","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.21037\/jtd.2018.04.112","article-title":"Pyrroloquinoline quinone attenuates cachexia-induced muscle atrophy via suppression of reactive oxygen species","volume":"10","author":"Xu","year":"2018","journal-title":"J. Thoracic Disease"},{"issue":"2 Pt A","key":"10.1016\/j.cellsig.2023.110847_bb0440","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.canlet.2014.02.019","article-title":"Acetate\/acetyl-CoA metabolism associated with cancer fatty acid synthesis: overview and application","volume":"356","author":"Yoshii","year":"2015","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.cellsig.2023.110847_bb0445","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1038\/s41598-017-02347-2","article-title":"Toll-like receptor 4 mediates Lewis lung carcinoma-induced muscle wasting via coordinate activation of protein degradation pathways","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cellsig.2023.110847_bb0450","first-page":"2567150","article-title":"Curcumin targeting NF-\u03baB\/ubiquitin-proteasome-system Axis ameliorates muscle atrophy in triple-negative breast Cancer Cachexia mice","volume":"2022","author":"Zhang","year":"2022","journal-title":"Mediat. Inflamm."},{"issue":"6","key":"10.1016\/j.cellsig.2023.110847_bb0455","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1159\/000488166","article-title":"Upregulation of IL-11, an IL-6 family cytokine, promotes tumor progression and correlates with poor prognosis in non-small cell lung Cancer","volume":"45","author":"Zhao","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"4","key":"10.1016\/j.cellsig.2023.110847_bb0465","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","article-title":"Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival","volume":"142","author":"Zhou","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.cellsig.2023.110847_bb0475","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s12885-017-3178-8","article-title":"Adipose tissue fibrosis in human cancer cachexia: the role of TGF\u03b2 pathway","volume":"17","author":"Alves","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cellsig.2023.110847_bb0495","doi-asserted-by":"crossref","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Sign. Transduct. Target. Therapy"},{"key":"10.1016\/j.cellsig.2023.110847_bb0505","article-title":"Role of Forkhead box O proteins in hepatocellular carcinoma biology and progression (review)","volume":"11","author":"Yang","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cellsig.2023.110847_bb0510","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.canlet.2018.08.006","article-title":"Fatty acid oxidation: An emerging facet of metabolic transformation in cancer","volume":"435","author":"Ma","year":"2018","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.cellsig.2023.110847_bb0515","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.21037\/jtd.2018.04.112","article-title":"Pyrroloquinoline quinone attenuates cachexia-induced muscle atrophy via suppression of reactive oxygen species","volume":"10","author":"Xu","year":"2018","journal-title":"J. Thoracic Disease"},{"issue":"6","key":"10.1016\/j.cellsig.2023.110847_bb0520","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/gerona\/61.6.575","article-title":"Interleukin-6 in aging and chronic disease: a magnificent pathway","volume":"61","author":"Maggio","year":"2006","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"8","key":"10.1016\/j.cellsig.2023.110847_bb0525","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/BF01636787","article-title":"The presence of tumor necrosis factor-alpha and its antibody in the sera of cachexic patients with gastrointestinal cancer","volume":"24","author":"Kiyama","year":"1994","journal-title":"Surg. Today"},{"issue":"7","key":"10.1016\/j.cellsig.2023.110847_bb0530","article-title":"What role do inflammatory cytokines play in cancer Cachexia?","volume":"14","author":"Malla","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.cellsig.2023.110847_bb0535","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.597675","article-title":"Inflammation and skeletal muscle wasting during Cachexia","volume":"11","author":"Webster","year":"2020","journal-title":"Front. Physiol."},{"issue":"2","key":"10.1016\/j.cellsig.2023.110847_bb0540","doi-asserted-by":"crossref","first-page":"552","DOI":"10.7150\/ijbs.76187","article-title":"Targeting breast cancer stem cells","volume":"19","author":"Zhang","year":"2023","journal-title":"Int. J. Biol. Sci."},{"issue":"4","key":"10.1016\/j.cellsig.2023.110847_bb0545","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nrc3237","article-title":"Combining immunotherapy and targeted therapies in cancer treatment","volume":"12","author":"Vanneman","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cellsig.2023.110847_bib546","doi-asserted-by":"crossref","first-page":"1221175","DOI":"10.3389\/fcell.2023.1221175","article-title":"Signaling pathways governing the maintenance of breast cancer stem cells and their therapeutic implications","volume":"11","author":"Ordaz-Ramos","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"issue":"41","key":"10.1016\/j.cellsig.2023.110847_bib547","doi-asserted-by":"crossref","first-page":"16239","DOI":"10.1073\/pnas.0705971104","article-title":"Activin A is a critical component of the inflammatory response, and its binding protein, follistatin, reduces mortality in endotoxemia","volume":"104","author":"Jones","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cellsig.2023.110847_bib548","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00592-010-0209-1","article-title":"STZ-induced skeletal muscle atrophy is associated with increased p65 content and downregulation of insulin pathway without NF-\u03baB canonical cascade activation","volume":"47","author":"Kelleher","year":"2010","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.cellsig.2023.110847_bib549","doi-asserted-by":"crossref","unstructured":"K. Tawara, H. Scott, J. Emathinger, C. Wolf, D. LaJoie, D. Hedeen, L. Bond, P. Montgomery, C. Jorcyk, HIGH expression of OSM and IL-6 are associated with decreased breast cancer survival: synergistic induction of IL-6 secretion by OSM and IL-1\u03b2, Oncotarget 10 (21) 2068\u20132085, doi:10.18632\/oncotarget.26699.","DOI":"10.18632\/oncotarget.26699"}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656823002619?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656823002619?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:14:23Z","timestamp":1760267663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656823002619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":94,"alternative-id":["S0898656823002619"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2023.110847","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer Cachexia and breast cancer stem cell signalling \u2013 A crosstalk of signalling molecules","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2023.110847","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110847"}}